0001556247-13-000003.txt : 20130826 0001556247-13-000003.hdr.sgml : 20130826 20130826102630 ACCESSION NUMBER: 0001556247-13-000003 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130822 FILED AS OF DATE: 20130826 DATE AS OF CHANGE: 20130826 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER RD CITY: TARRYTOWN STATE: NY ZIP: 10591-6707 BUSINESS PHONE: 9143477000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RYAN ARTHUR F CENTRAL INDEX KEY: 0001187443 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 131059532 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2013-08-22 0 0000872589 REGENERON PHARMACEUTICALS INC REGN 0001187443 RYAN ARTHUR F 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 1 0 0 0 Common Stock 2013-08-22 4 M 0 5000.0 18.61 A 39855 D Common Stock 2013-08-22 4 F 0 393.0 236.64 D 39462 D Common Stock 2013-08-22 4 M 0 10000.0 24.41 A 49462 D Common Stock 2013-08-22 4 F 0 1031.0 236.64 D 48431 D Common Stock 2013-08-22 4 M 0 10000.0 33.42 A 58431 D Common Stock 2013-08-22 4 F 0 1412.0 236.64 D 57019 D Common Stock 2013-08-22 4 M 0 5000.0 57.11 A 62019 D Common Stock 2013-08-22 4 F 0 1206.0 236.64 D 60813 D Common Stock 2013-08-23 4 S 0 10958.0 238.47 D 49855 D Non-Qualified Stock Option (right to buy) 18.61 2013-08-22 4 M 0 5000.0 D 2019-01-02 Common Stock 5000 0 D Non-Qualified Stock Option (right to buy) 24.41 2013-08-22 4 M 0 10000.0 D 2020-01-04 Common Stock 10000 0 D Non-Qualified Stock Option (right to buy) 33.42 2013-08-22 4 M 0 10000.0 D 2021-01-03 Common Stock 10000 5000 D Non-Qualified Stock Option (right to buy) 57.11 2013-08-22 4 M 0 5000.0 D 2022-01-03 Common Stock 5000 10000 D Represents volume-weighted average price of sales of 10,958 shares of Company stock on August 23, 2013 at prices ranging from $238.24 to $238.65. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 23, 2013 at each separate price. The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant. Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case. /s/**Arthur F. Ryan 2013-08-24